APA (7th ed.) Citation

Luo, M., Wang, X., Yu, G., Ji, J., Li, L., & Song, F. (2025). Development of a bispecific antibody–drug conjugate targeting EpCAM and CLDN3 for the treatment of multiple solid tumors. Experimental Hematology & Oncology, 14(1), 1. https://doi.org/10.1186/s40164-025-00624-9

Chicago Style (17th ed.) Citation

Luo, Meiying, Xiaohuan Wang, Guoji Yu, Jing Ji, Long Li, and Fan Song. "Development of a Bispecific Antibody–drug Conjugate Targeting EpCAM and CLDN3 for the Treatment of Multiple Solid Tumors." Experimental Hematology & Oncology 14, no. 1 (2025): 1. https://doi.org/10.1186/s40164-025-00624-9.

MLA (9th ed.) Citation

Luo, Meiying, et al. "Development of a Bispecific Antibody–drug Conjugate Targeting EpCAM and CLDN3 for the Treatment of Multiple Solid Tumors." Experimental Hematology & Oncology, vol. 14, no. 1, 2025, p. 1, https://doi.org/10.1186/s40164-025-00624-9.